Xgeva

The Top Line
Podcast

A closer look at pharma’s top patent losses in 2025

This week on "The Top Line," we explore the potential impacts of this year's sizable patent cliff on the pharma industry at large.
clock time delay cancelled month year hour

The top 10 drugs losing US exclusivity in 2025

Mar 17, 2025 3:00am
An artists 3D illustration of bones spongy structure seen close up

Amgen fends off Celltrion's proposed Prolia biosim until June

Jan 28, 2025 11:46am
FDA

Sandoz wins FDA nods for first Prolia, Xgeva biosimilars

Mar 6, 2024 9:52am
Prolia

Amgen's Prolia flagged by the FDA for risk of hypocalcemia

Jan 19, 2024 3:35pm
Patents on file

Amgen takes Novartis' Sandoz to court over bone med biosimilar

May 5, 2023 9:35am